Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up

• Andrés J. M. Ferreri,
• Gerald Illerhaus,
• Jeanette K. Doorduijn,
• Dorothee P. Auer,
• Jacoline E. C. Bromberg,
• Teresa Calimeri,
• Kate Cwynarski,
• Christopher P. Fox,
• Khê Hoang‐Xuan,
• Denis Malaise,
• Maurilio Ponzoni,
• Elisabeth Schorb,
• Carole Soussain,
• Lena Specht,
• Emanuele Zucca,
• Christian Buske,
• Mats Jerkeman,
• Martin Dreyling,
• EHA and ESMO Guidelines Committees

Affiliations

Andrés J. M. Ferreri

Lymphoma Unit, IRCCS San Raffaele Scientific Institute Milan Italy

Gerald Illerhaus

Department of Hematology Oncology, Stem‐Cell Transplantation and Palliative Care, Klinikum Stuttgart Stuttgart Germany

Jeanette K. Doorduijn

Department of Haematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam The Netherlands

Dorothee P. Auer

Mental Health & Clinical Neurosciences Unit, School of Medicine University of Nottingham Nottingham UK

Jacoline E. C. Bromberg

Department of Neuro‐Oncology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam The Netherlands

Teresa Calimeri

Lymphoma Unit, IRCCS San Raffaele Scientific Institute Milan Italy

Kate Cwynarski

Department of Haematology University College Hospital London UK

Christopher P. Fox

School of Medicine University of Nottingham Nottingham UK

Khê Hoang‐Xuan

Department of Neurology 2 Mazarin APHP, Groupe Hospitalier Pitié‐Salpêtrière, Sorbonne Université, ICM Paris France

Denis Malaise

Department of Ophthalmology Institut Curie Paris France

Maurilio Ponzoni

Lymphoma Unit, IRCCS San Raffaele Scientific Institute Milan Italy

Elisabeth Schorb

Department of Medicine I, Medical Center, Faculty of Medicine University of Freiburg Freiburg Germany

Carole Soussain

Clinical Hematology Unit, Institut Curie St Cloud France

Lena Specht

Department of Oncology, Rigshospitalet University of Copenhagen Copenhagen Denmark

Emanuele Zucca

Clinic of Medical Oncology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale Bellinzona Switzerland

Christian Buske

Institute of Experimental Cancer Research, Comprehensive Cancer Center Ulm University Hospital of Ulm Ulm Germany

Mats Jerkeman

Department of Oncology Skåne University Hospital and Lund University Lund Sweden

Martin Dreyling

Department of Medicine III LMU University Hospital Munich Munich Germany

EHA and ESMO Guidelines Committees